Skip to main content
Nextage Therapeutics Ltd (TLV:NXTG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
66.00
-19.00 (-22.35%)
Jun 12, 2025, 5:27 PM IDT

Nextage Therapeutics Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY null FY null
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
-0.4-3.262.03
Short-Term Investments
---0.10.04
Cash & Short-Term Investments
-0.4-3.362.07
Cash Growth
---62.49%-
Accounts Receivable
---0.03-
Other Receivables
0.060.4-0.660.44
Receivables
0.060.4-0.680.44
Prepaid Expenses
---0.080.01
Other Current Assets
0.260.09-0.03-
Total Current Assets
0.320.89-4.162.51
Property, Plant & Equipment
0.040.21-0.120.24
Other Intangible Assets
----1.32
Total Assets
0.351.1-4.274.07
Accounts Payable
0.240.12-0.450.21
Accrued Expenses
5.373.22-1.91.03
Short-Term Debt
0.160.23---
Current Portion of Long-Term Debt
---0.230.26
Current Portion of Leases
0.050.08---
Other Current Liabilities
0.030.08---
Total Current Liabilities
5.853.73-2.581.5
Long-Term Debt
---1.120.58
Long-Term Leases
-0.07---
Other Long-Term Liabilities
0.040.04-0.070.54
Total Liabilities
5.893.83-3.762.62
Common Stock
-60.54-52.2950.76
Additional Paid-In Capital
63.151.43-4.792.71
Retained Earnings
----29.79-22.06
Comprehensive Income & Other
-68.67-64.86--27.54-29.96
Total Common Equity
-5.52-2.9--0.251.45
Minority Interest
-0.020.16-0.77-
Shareholders' Equity
-5.54-2.74-0.521.45
Total Liabilities & Equity
0.351.1-4.274.07
Total Debt
0.210.38-1.350.84
Net Cash (Debt)
-0.210.03-2.021.23
Net Cash Growth
---64.09%-
Net Cash Per Share
-0.010.00-0.080.11
Filing Date Shares Outstanding
33.729.1827.8526.1411.43
Total Common Shares Outstanding
33.729.1827.8526.1411.43
Working Capital
-5.54-2.84-1.581.01
Book Value Per Share
-0.16-0.10--0.010.13
Tangible Book Value
-5.52-2.9--0.250.13
Tangible Book Value Per Share
-0.16-0.10--0.010.01
Machinery
0.190.19---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.